Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aanchal Sugandh

Amazon Aims to Take Over the GLP-1 Market Next. Will That Move the Needle for AMZN Stock?

Amazon.com (AMZN) is sharpening its healthcare ambitions with a calculated push, introducing a program that streamlines access to weight-loss treatments while fundamentally reengineering how GLP-1 therapies reach patients. 

The move places the company in direct competition with entrenched leaders like Eli Lilly and Company (LLY) and Novo Nordisk A/S (NVO), but with a fundamentally different playbook built on integration and scale.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.